How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,912 results for

physical therapy

Latest & greatest

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy

testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005; 90: 1502-1510. Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf) 2005; 63: 280-293. Allan CA, Strauss BJ, Burger HG, et al. Testosterone therapy prevents gain in visceral adipose tissue and loss (...) Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy | The Medical Journal of Australia mja-search search Use the for more specific terms. Title contains Body contains Date range from Date range to Article type Author's surname Volume First page doi: 10.5694/mja__.______ Search Reset

2016 MJA Clinical Guidelines

142. Occupational Therapy for Adults Undergoing Total Hip Replacement

Occupational Therapy for Adults Undergoing Total Hip Replacement Specialist Section Trauma and Orthopaedics Occupational therapy for adults undergoing total hip replacement Practice guideline College of Occupational Therapists T i n 2013.indd 1 21/02/2013 11:09Cover photographs (inset, top right) ©Tessa Woodfine About the publisher The College of Occupational Therapists is a wholly owned subsidiary of the British Association of Occupational Therapists (BAOT) and operates (...) as a registered charity. It represents the profession nationally and internationally, and contributes widely to policy consultations throughout the UK. The College sets the professional and educational standards for occupational therapy, providing leadership, guidance and information relating to research and development, education, practice and lifelong learning. In addition, 11 accredited specialist sections support expert clinical practice. 2/13 Mrs Jeffries, a service user, describes her experience

2012 British Association of Occupational Therapists

143. Management of Venous Leg Ulcers: Clinical Practice Guidelines of the Society for Vascular Surgery and the American Venous Forum

Committee—Venous Leg Ulcer Chair: Thomas F. O’Donnell Jr, MD (Cardiovascular Center, Tufts Medical Center, Boston, Mass) Vice Chair: Marc A. Passman, MD (Division of Vascular Surgery and Endovascular Therapy. University of Alabama at Birmingham, Birmingham, Ala; Birmingham Veterans Administration Medical Center, Birmingham, Ala) Committee Members: Mary E. Cummings, MD (University of Michigan, Ann Arbor, Mich) Michael C. Dalsing, MD (Indiana University School of Medicine, IU Health Care System (...) therapy after 4 to 6 weeks of treatment and for all ulcers with atypical features. [GRADE - 1; LEVEL OF EVIDENCE - C] Guideline 3.6 : Laboratory Evaluation We suggest laboratory evaluation for thrombophilia for patients with a history of recurrent venous thrombosis and chronic recurrent venous leg ulcers. [GRADE - 2; LEVEL OF EVIDENCE - C] Guideline 3.7 : Arterial Testing We recommend arterial pulse examination and measurement of ankle-brachial index on all patients with venous leg ulcer. [GRADE - 1

Full Text available with Trip Pro

2014 American Venous Forum

144. Recommendations for Preprocedural Fasting for the Breastfed Infant: NPO Guidelines

such as circumcision with a local block, diagnostic examinations, placement of pe- ripheral intravenous lines, and drawing blood can be performed without sedation or general anesthesia. A procedurethatisconsideredminorshouldcauseminimal physical trauma and psychological impact, therefore not requiring sedation. Without sedation, the infant can pro- tect his or her airway with an intact cough/gag re?ex, and thus fasting is not required (I). 10,11 The need for se- dation should be decided upon at the physician’s (...) procedures requiring pharmacologic immobilization or sedation. Procedures that are more painful or stressful, such as bone marrow bi- opsies or lumbar puncture with intrathecal chemo- therapy administration, require sedation (III). 2 Other procedures may require a motionless patient, such as central line placement or magnetic resonance imaging/ computed tomography exams. In these situations, a li- censed anesthesia provider may need to perform a generalanesthetic,buttheseprocedurescanpossiblybe performed

2012 Academy of Breastfeeding Medicine

145. Persistent Pain with Breastfeeding

, Versteegen GJ, et al. Mind- fulness, acceptance and catastrophizing in chronic pain. PLoS One 2014;9:e87445. 42. BergbomS,BoersmaK,OvermeerT,etal.Relationshipamong pain catastrophizing, depressed mood, and outcomes across physical therapy treatments. Phys Ther 2011;91:754–764. 43. WilliamsAC,EcclestonC,MorleyS.Psychologicaltherapies forthemanagementofchronicpain(excludingheadache)in adults. Cochrane Database Syst Rev 2012;11:CD007407. 44. Buryk M, Bloom D, Shope T. Ef?cacy of neonatal release (...) ’ efforts. History and Examination Assessmentofpersistentpainbeginswithacarefulhistory and physical examination of both mother and infant, with particular attention to the following: Breastfeeding history B Previous breastfeeding experiences/problems/pain B Nipple/breast sensitivity before pregnancy B Milk supply (ongoing engorgement, high supply versus low supply) B Pattern of breastfeeding (frequency, duration, one, or both breasts) 1 Department of Obstetrics and Gynecology, University of Texas

2016 Academy of Breastfeeding Medicine

146. Nonpharmacological Management of Procedure-Related Pain in the Breastfeeding Infant

as demonstrated in animal models. 3,7 Moreover, pain is a source of concern and distress for new parents and may disturb mother–infant bonding. 8 Pain re- duction therapies are often underused for the numerous minor procedures that are part of routine medical and nursing care for neonates. 9,10 Growing scienti?c and clinical evidence from both animal and human newborns points to the ef?cacy of natural, nonpharmacological interventions to reduce pain due to minor procedures. Parents should be educated about (...) be invited to breastfeed the infant during painful procedures (IV). 4. Older than 12 months. The upper age limit of effec- tiveness of sucrose as a pain reducer has not been fully studied, and sucrose, therefore, cannot be re- commended as a pain reducer in children older than 12 months at this time (IA). 50,52,61 A publication of workshop proceedings reviewing the evidence for other techniques such as physical, psychological, and pharmacological interventions shows a range of non- pharmacological

2016 Academy of Breastfeeding Medicine

147. Contraception During Breastfeeding

and sexual activity, should be explored. A woman’s history of unplanned pregnancy and short interpregnancy interval should be reviewed and discussed. 6. Previous lactation experience/medical conditions Prior insuf?cient milk supply or inadequate infant growth Prior breastfeeding experience did NOT meet goals (either exclusivity or duration), AND supply was a potential reason. Physical examination suggestive of insuf?cient glandular tissue Prior breast surgery Medical conditions potentially adversely (...) con- tinued contraception. LNG options are slightly more effec- tivethantheCOCandalsoarelesslikelytocausesigni?cant nauseaandvomiting. 35 Furthermore,intheory,LNGoptions would be less likely to impact lactation. A pharmacologic studyof12breastfeedingmothersfoundtheestimatedinfant exposure to the maternal treatment of 1.5mg of LNG was 1.6lg on the day of therapy. 36 A single observational study comparing progestin-only with estrogen-containing options for postcoital contraception found

2015 Academy of Breastfeeding Medicine

148. Guidelines for Blood Glucose Monitoring and Treatment of Hypoglycemia in Term and Late-Preterm Neonates

. B. Infants with clinical signs or with plasma glucose levels 45mg/dL (>2.5mmol/L). 4. Adjust the IV rate by blood glucose concentration. 5. Encourage frequent breastfeeding after initiation of IV therapy. 6. Monitor glucose concentrations before feedings while gradually weaning from the IV solution, until values are stabilized off IV ?uids. 7. Carefully document physical examination, screening values, laboratory con?rmation, treatment, and chan- ges in clinical condition (i.e., response (...) Clinical manifestations of hypoglycemia The clinical manifestations of hypoglycemia are nonspe- ci?c,occurringwithvariousotherneonatalproblems.Evenin the presence of an arbitrary low glucose level, the physician mustassessthegeneralstatusoftheinfantbyobservationand physical examination to rule out other disease entities and processesthatmayneedadditionallaboratoryevaluationand treatment.SomecommonclinicalsignsarelistedinTable4. A recent study found that of the 23 maternal/infant risk factors and infant

2014 Academy of Breastfeeding Medicine

149. WHO Guidelines on Integrated Care for Older People (ICOPE)

and respite care, these further two were not supported due to insufficient evidence. 2.5 Document preparation and peer review In addition to the GDG members, four peer reviewers provided expert input from specialized fields – psychiatry, nutrition, physical therapy and geriatrics. A preliminary version of these guidelines and the evidence profiles prepared by WHO staff and the GDG were circulated to the peer reviewers and the WHO steering group. All inputs and remarks from reviewers were discussed (...) -making during the guideline development group meeting 6 2.5 Document preparation and peer review 6 3 Evidence and recommendations 7 3.1 Module I: Declining physical and mental capacities 8 3.2 Module II: Geriatric syndromes 17 3.3 Module III: Caregiver support 21 4 Implementation considerations 25 5 Publication, dissemination and evaluation 29 5.1 Publication and dissemination 29 5.2 Monitoring and evaluation 29 5.3 Future review and update 30 References 31 Annex 1: Guideline development group (GDG

2017 World Health Organisation Guidelines

150. Preventive chemotherapy to control soil-transmitted helminth infections in at-risk population groups

of adverse effects in specific populations, such as individuals living with HIV (especially in children and those on antiretroviral therapy), breastfeeding mothers and their infants, pregnant mothers and their unborn babies, and infants (less than 12 months of age); and l factors that influence compliance with large-scale preventive chemotherapy programmes, including the values and preferences of children, adolescent girls and adult women, as well as the prevailing social attitudes about treatment

2017 World Health Organisation Guidelines

151. WHO guideline on syphilis screening and treatment for pregnant women

(such as chancroid) approach elimination in many countries (17, 18). As recommended during the STI expert consultation, treatment guidelines for genital ulcer disease (GUD) should be updated to include HSV-2 treatment and a longer treatment duration for HSV-2 should be explored. In addition, suppressive therapy for HSV-2 should be considered in areas with high HIV prevalence (17). The chronic, lifelong nature of viral infections also requires that renewed attention be paid to developing effective prevention (...) of therapy may be the key to improving efficacy. Sex Transm Infect. 2012;88(3):154–6. doi:10.1136/sextrans-2011-050385. 15. Wang S, John Papp , Stamm W, Peeling R, Martin D, Holmes K. Evaluation of antimicrobial resistance and treatment failures for Chlamydia trachomatis: a meeting report. J Infect Dis. 2005;191:917–23. 16. Vázquez F, García J, Pérez F, Palacio V. Trichomonas vaginalis: tratamiento y resistencia a nitroimidazoles. Enfermedades Infecciosas y Microbiologia Clinica. 2001;19:114–24. doi

2017 World Health Organisation Guidelines

152. Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline

the balance of desirable and undesirable consequences, quality of evidence, feasibility, and acceptability of various interventions, the Task Force made: 1) a strong recommendation for noninvasive mechanical ventilation of patients with acute or acute-on-chronic respiratory failure; 2) conditional recommendations for oral corticosteroids in outpatients, oral rather than intravenous corticosteroids in hospitalised patients, antibiotic therapy, home-based management, and the initiation of pulmonary (...) rehabilitation within 3 weeks after hospital discharge; and 3) a conditional recommendation against the initiation of pulmonary rehabilitation during hospitalisation. The Task Force provided recommendations related to corticosteroid therapy, antibiotic therapy, noninvasive mechanical ventilation, home-based management, and early pulmonary rehabilitation in patients having a COPD exacerbation. These recommendations should be reconsidered as new evidence becomes available. Abstract New guideline

2017 European Respiratory Society

153. Mesothelioma fact sheet

of exposure. However, most people who have been exposed to asbestos do not develop mesothelioma. The process that leads to the development of mesothelioma is not well understood. Although exposure to asbestos is the only known risk factor for mesothelioma, some people who have had no clear exposure to asbestos develop mesothelioma. This suggests that there might be other causes, such as a gene mutation or prior radiation therapy to the chest for another type of cancer. However, these links have not been (...) proven. Smoking does not seem to be a risk factor for mesothelioma. However, people with mesothelioma who smoke may be advised to quit because smoking might interfere with cancer treatment. How is mesothelioma diagnosed? You might have a number of tests to investigate your symptoms and confirm a diagnosis of mesothelioma, including: medical history and physical examination – a physical exam can pick up a pleural effusion, which is often the earliest sign of asbestos-related disease biopsy, where

2017 Cancer Australia

154. Canadian guidelines for controlled pediatric donation after circulatory determination of death-summary report

working groups and finalized during meetings of working group leads and the planning committee. External review was provided by pediatric, critical care, and critical care nursing professional societies and patient partners. Results: We generated 63 Good Practice Statements and seven Grading of Recommendations Assessment, Development, and Evaluation recommendations covering 1) ethics , consent, and withdrawal of life-sustaining therapy, 2) eligibility, 3) withdrawal of life-sustaining therapy (...) have active research and academic activities in organ donation. The guideline development committee adhered to a rigorous development process based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) methods and consistent with recommendations from several national and international bodies ( ). The scope of the guideline included only controlled pDCD (e.g., after planned withdrawal of life-sustaining therapies [WLSTs]). Specifically, we defined uncontrolled pDCD

Full Text available with Trip Pro

2017 CPG Infobase

155. A Practical Approach to the Management of Continuous Glucose Monitoring (CGM) / Real-Time Flash Glucose Scanning (FGS) in Type 1 Diabetes Mellitus in Children and Young People Under 18 Years

under the supervision of a multidisciplinary team who are experienced and appropriately trained in integrated sensor augmented insulin pump therapy” There must be agreement that the CYP with diabetes and/or their parents(s)/carer(s): ? agrees to use the sensors for at least 70% of the time ? understands how to use it and is physically able to use the system ? agrees to use the system while having a structured education programme on diet and lifestyle, and counselling. Once commenced, the sustained (...) Started with the CGM or FGS System 22 Appendix A: Literature Search – Evidence for CGM or Sensor Augmented Pump Therapy 22 Appendix B: Review of Evidence and Limitations of Evidence Underpinning NICE Recommendations .. 24 Appendix C: Criteria Used to Assess Levels of Evidence and Strength of Recommendations 42 Appendix D: Scores to Assess Hypoglycaemia 43 Appendix E: Scales That Can Be Used to Assess Hypoglycaemia 44 References 48 Clinical Guideline A Practical Approach to the Management of Continuous

2017 British Society for Paediatric Endocrinology and Diabetes

156. Commissioning guide: Faecal incontinence

has shown a benefit from nurse led therapies. 5 A large majority of patients will not be offered any surgery before a trial of nurse- or therapist-led therapies. ? In the best resourced units 3-5 sessions of nurse- or therapist-led treatment result in patient satisfaction rates in excess of 80% with the majority of patients not seeing a doctor and avoiding surgical intervention. Results also remain stable at one year. ? The commissioning of Sacral Nerve Stimulation (SNS) sits outside of this guide (...) and overflow and assess anal tone and squeeze Initial bowel management ? Dietary modification ? Medication ? Advice on use of continence products (see appendix 2) Offer all patients: ? reassurance and lifestyle advice ? access to help with relevant physical, emotional, psychological and social issues ? advice about relevant support groups ? advice on self-management of symptoms Commissioning guide 2017 Faecal Incontinence 4 All individuals who continue to experience symptoms of faecal incontinence should

2017 Association of Coloproctology of Great Britain and Ireland

157. Child abuse and neglect

Past child abuse or neglect 46 Physical abuse 46 Practitioner 46 Prader-Willi syndrome 46 Regulated profession 46 Sexual abuse 46 Special guardian 47 Vulnerability factor 47 Putting this guideline into practice 48 Recommendations for research 51 1 Recognition of child sexual abuse 51 Child abuse and neglect (NG76) © NICE 2019. All rights reserved. Subject to Notice of rights ( conditions#notice-of-rights). Page 4 of 582 Recognition of risk and prevention of female (...) been abused or neglected 57 Update information 58 Child abuse and neglect (NG76) © NICE 2019. All rights reserved. Subject to Notice of rights ( conditions#notice-of-rights). Page 5 of 58This guideline is the basis of QS179. Ov Overview erview This guideline covers recognising and responding to abuse and neglect in children and young people aged under 18. It covers physical, sexual and emotional abuse, and neglect. The guideline aims to help anyone whose work

2017 National Institute for Health and Clinical Excellence - Clinical Guidelines

158. Responding to large-scale traumatic events and acts of terrorism

- mation should also be made available to the family members of those directly affected by the incident (for example, the leaflet produced by Royal College of Psychiatrists (2014)). 4 The UK government should implement an evidence-based ‘screen and treat’ approach (Royal College of Psychiatrists, 2014) a suitable period (such as a few months) after the event, as people frequently do not seek help. This is in line with the drive to achieve parity of esteem between mental and physical health as most (...) cases of PTSD are highly treatable. Effective treatment can restore mental health and employ- ability and help to sustain relationships with family members, friends and colleagues. Chronic PTSD, left untreated, is debilitating for both the individuals and their families. 5 Current NHS trauma services need to be better provisioned. For instance, the Improving Access to Psychological Therapies (IAPT) programme provides treatment for PTSD, but its successful recovery rate is just 36%. NHS treatment

2016 Royal College of Psychiatrists

159. Psychiatric reports: preparation and use in cases involving asylum, removal from the UK or immigration detention

the psychiatrist’s expertise; z that the psychiatrist will not treat the applicant for any illness following the completion of the report but may, with consent, speak or write to their GP about treatment for physical or mental health problems. Family members The psychiatrist may find it valuable to speak pri - vately with the applicant’s family members, but should be aware of cultural taboos and of the need The interviewCollege Report 199 10 for informed consent. In general, family members should not be present (...) they become distressed. Professional interpret- ers are always to be preferred, particularly those with experience in cross-cultural therapy or similar work. An assurance that the interpreter under- stands confidentiality should be described and translated, even if the psychiatrist is aware that the interpreter understands this duty. Throughout the interview, the psychiatrist must be satisfied that: z the applicant and the interpreter understand each other (the capacity to mutually under- stand one

2016 Royal College of Psychiatrists

160. Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals

Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals POSITION PAPER Open Access Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals J. Koziorowski 1* , M. Behe 2 , C. Decristoforo 3 , J. Ballinger 4 , P. Elsinga 5 , V. Ferrari 6 , P. Kolenc Peitl 7 , S. Todde 8 and T. L. Mindt 9* * Correspondence: jacek.koziorowski@regionostergotland. se; 1 Department of Radiation Physics (...) Practice (GLP). For therapy For the anticancer use of RPs (immunoradiotherapy, endoradiotherapy) the “ICH guideline S9 on nonclinical evaluation for anticancer pharmaceuticals” can be employed. In these cases in particular genetoxicity testing for Phase I and II studies may notbe required. In accordance with scenario in section <100 µg, the argument of molar equivalence may be used. Conclusion The concept of differentiating 3 toxicological limits will clarify the requirements for application

2016 European Association of Nuclear Medicine


Guidelines – filter by country